Analyst Reco. Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 02:30:02 13/01/2026 am IST			5-day change	1st Jan Change
96.95 ^USD	-0.59%		-0.42%	+0.93%

13/01	Medtronic plc Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM
13/01	Medtronic, Precision Neuroscience Partner on Neurosurgery Platforms	MT

Analyst Reco.

09/01	Bernstein Adjusts Price Target on Medtronic to $112 From $111, Maintains Outperform Rating	MT
06/01	William Blair Upgrades Medtronic to Outperform From Market Perform	MT
06/01	Analyst recommendations: AT&T, BoA, Comcast, MetLife, Reddit…
18/12	Truist Securities Cuts Price Target on Medtronic to $107 From $110, Maintains Hold Rating	MT
16/12	Baird Adjusts Price Target on Medtronic to $103 From $109, Maintains Neutral Rating	MT
08/12	Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla…
25/11	Daiwa Securities Adjusts Medtronic Price Target to $117 From $104, Maintains Buy Rating	MT
19/11	Truist Adjusts Price Target on Medtronic to $110 From $103, Maintains Hold Rating	MT
19/11	UBS Adjusts Price Target on Medtronic to $102 From $95, Maintains Neutral Rating	MT
19/11	Barclays Adjusts Price Target on Medtronic to $111 From $109, Maintains Overweight Rating	MT
19/11	Rothschild & Co Redburn Adjusts Price Target on Medtronic to $111 From $101, Maintains Buy Rating	MT
19/11	RBC Raises Price Target on Medtronic to $118 From $111, Keeps Outperform Rating	MT
19/11	Mizuho Adjusts Price Target on Medtronic to $125 From $115, Maintains Outperform Rating	MT
19/11	Deutsche Bank Adjusts Price Target on Medtronic to $100 From $85, Maintains Hold Rating	MT
19/11	Jefferies Adjusts Price Target on Medtronic to $110 From $94, Maintains Hold Rating	MT
19/11	Bernstein Adjusts Price Target on Medtronic to $111 From $98, Maintains Outperform Rating	MT
19/11	Piper Sandler Adjusts Price Target on Medtronic to $105 From $90, Maintains Neutral Rating	MT
19/11	Baird Adjusts Price Target on Medtronic to $109 From $103, Maintains Neutral Rating	MT
19/11	Wells Fargo Adjusts Price Target on Medtronic to $114 From $100, Maintains Overweight Rating	MT
19/11	Leerink Partners Adjusts Price Target on Medtronic to $120 From $114, Maintains Outperform Rating	MT
19/11	Morgan Stanley Adjusts Price Target on Medtronic to $117 From $107, Maintains Overweight Rating	MT
19/11	Evercore ISI Adjusts Price Target on Medtronic to $115 From $107, Maintains Outperform Rating	MT
19/11	Citigroup Adjusts Price Target on Medtronic to $117 From $112, Maintains Buy Rating	MT
19/11	TD Cowen Adjusts Price Target on Medtronic to $119 From $106, Maintains Buy Rating	MT
19/11	Goldman Sachs Upgrades Medtronic to Neutral From Sell, Adjusts Price Target to $111 From $81	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Medtronic still hiding behind its status as a dividend aristocrat

May 22, 2025 at 01:54 pm IST